Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone for pain in fibromyalgia
2015-002972-26Phase 4Completed
- Sponsor
- Smerteklinikken
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of naltrexone in fibromyalgia (FM) and chronic pain, sponsored by Smerteklinikken. Primary endpoint: Pain intensity. Started Oct 2015; status: completed.
02
Drugs
naltrexone
03
Conditions
fibromyalgia (FM)chronic pain
Beyond the preview
Go deeper on 2015-002972-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002972-26.